Advertisement

An FDA panel supports Merck COVID drug in mixed vote

A COVID-19 antiviral pill called molnupiravir from Merck and Ridgeback Biotherapeutics is being considered by the Food and Drug Administration for emergency use in the coronavirus pandemic. (Merck & Co Inc./Handout via Reuters)
A COVID-19 antiviral pill called molnupiravir from Merck and Ridgeback Biotherapeutics is being considered by the Food and Drug Administration for emergency use in the coronavirus pandemic. (Merck & Co Inc./Handout via Reuters)

Related:

Advertisement

More from WBUR

Listen Live
Close